XML 23 R14.htm IDEA: XBRL DOCUMENT v3.25.3
STOCKHOLDERS’ EQUITY
 9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 7— STOCKHOLDERS’ EQUITY

 

PUBLIC OFFERING

 

On January 12, 2024 the underwriter exercised its over-allotment option as to 372,110 shares of common stock for net proceeds after discounts and commission of $192,156.

 

SHARES TO BE ISSUED

 

As of September 30, 2025 and 2024, there were 3,076,871 and 2,657,058, respectively, shares to be issued whose issuance has been deferred under the terms of employment and consulting agreements with officers and directors and other employees of Milestone Scientific. Such shares will be issued to each party upon termination of their employment or other relationship with the Company. 

 

As of September 30, 2025 and 2024, there were 631,792 and 527,625, respectively, shares to be issued to non-employees, that will be issued to non-employees for services rendered. The number of shares was fixed by contract before the date of grant, subject to performance, and were fully earned upon the grant date.

 

The following table summarizes information about shares to be issued for the nine month periods ending September 30, 2025 and 2024.

 

   September 30, 2025   September 30, 2024 
         
Shares-to-be-issued, outstanding January 1, 2025 and 2024, respectively   3,393,017    3,098,917 
Granted in current period   315,646    438,868 
Issued in current period   -    (353,102)
Shares-to be issued outstanding September 30, 2025 and 2024, respectively   3,708,663    3,184,683